Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluation.
about
Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV).SLE disease patterns in a Danish population-based lupus cohort: an 8-year prospective study.Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus.Diffuse alveolar hemorrhage in systemic lupus erythematosus: a single center retrospective study in Taiwan.Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment.Novel approaches to therapy for systemic lupus erythematosus: update 2005.Time perspective predicts the progression of permanent organ damage in patients with systemic lupus erythematosus.Health care and burden of illness in systemic lupus erythematosus compared to rheumatoid arthritis: results from the National Database of the German Collaborative Arthritis Centres.Validation and evaluation of the German Brief Index of Lupus Damage (BILD)--a self-reported instrument to record damage in systemic lupus erythematosus.Current causes of death in systemic lupus erythematosus in Europe, 2000--2004: relation to disease activity and damage accrual.The causes of death in Korean patients with systemic lupus erythematosus over 11 years.Factors influencing the health related quality of life in patients with systemic lupus erythematosus: long-term results (2001--2005) of patients in the German Lupus Erythematosus Self-Help Organization (LULA Study).Occurrence of systemic lupus erythematosus in a Danish community: an 8-year prospective study.Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosus.
P2860
Q31129756-4AF5C233-5B50-4A88-A153-8CD6F6B78E2FQ33387223-A3A29CE1-064E-4F56-A0D0-63523E4B0F6AQ33871944-3003DE90-132F-4D92-BA3B-809E56CDAFE2Q35020446-CBE370D0-7DDF-43BA-B2A6-393BB9AF3387Q35552600-E710DBD1-F6E7-44C7-A22A-DE9A43B0D6F0Q37754557-9C6FF245-E175-495F-8DFE-877250757ED2Q40573631-0196D621-78D8-48AD-8BAD-E9557007C212Q44089331-3DA75F57-C749-42F6-A59F-9E2C14F6025FQ44476349-DF461BA8-3D89-4780-9F6E-D22DF5351DA8Q44699349-80A67C32-EF7B-44D0-8E5F-E28937783D9EQ46216656-CD828D5D-F4EF-454B-830B-CC0B39044FBCQ48795555-BEAD395D-73ED-4AEF-909F-5F1A0A58EBAAQ50548860-65177A12-2534-44CB-BF79-E7892E68D6D5Q51572777-D1676703-0619-4E2E-AFE6-B27FE4455C65
P2860
Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluation.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Systemic lupus erythematosus. ...... t 10 years: second evaluation.
@ast
Systemic lupus erythematosus. ...... t 10 years: second evaluation.
@en
type
label
Systemic lupus erythematosus. ...... t 10 years: second evaluation.
@ast
Systemic lupus erythematosus. ...... t 10 years: second evaluation.
@en
prefLabel
Systemic lupus erythematosus. ...... t 10 years: second evaluation.
@ast
Systemic lupus erythematosus. ...... t 10 years: second evaluation.
@en
P2093
P2860
P1433
P1476
Systemic lupus erythematosus. ...... t 10 years: second evaluation.
@en
P2093
H Chwalinska-Sadowska
H G van den Brink
H M Moutsopoulos
P2860
P356
10.1191/096120301666282314
P577
2001-01-01T00:00:00Z